17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents

Details for Australian Patent Application No. 2001276497 (hide)

Owner Glaxo Group Limited

Inventors Payne, Jeremy John; Jones, Paul; Biggadike, Keith

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001276497

PCT Pub. Number WO02/12266

Priority 0108800 07.04.01 GB; 0019172 05.08.00 GB

Filing date 3 August 2001

Wipo publication date 18 February 2002

Acceptance publication date 7 April 2005

International Classifications

C07J 031/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

A61K 031/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 005/44 Drugs for disorders of the endocrine system

C07J 003/00 Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom

C07J 071/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

C07J 033/00 Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

7 April 2005 Application Accepted

  Published as AU-B-2001276497

4 August 2005 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001276498

2001276496